Comparison of the therapeutic effects of human and mouse adipose-derived stem cells in a murine model of lipopolysaccharide-induced acute lung injury
Authors:
- Shijia ZhangSZShijia Zhang
- Svitlana D DanchukSDSvitlana D Danchuk
- Kathleen Mp ImhofKIKathleen Mp Imhof
- Julie A SemonJSJulie A Semon
- Brittni A ScruggsBSBrittni A Scruggs
- Ryan W BonvillainRBRyan W Bonvillain
- Amy L StrongASAmy L Strong
- Jeffrey M GimbleJGJeffrey M Gimble
- Aline M BetancourtABAline M Betancourt
- Deborah E SullivanDSDeborah E Sullivan
- Bruce A BunnellBruce A Bunnell
Open Access
- 29 January 2013
- journal article
- research article
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 4 (1) , 13
Abstract
Introduction: Adipose-derived stem cells (ASCs) have emerged as important regulators of inflammatory/immune responses in vitro and in vivo and represent attractive candidates for cell-based therapies for diseases that involve excessive inflammation. Acute lung injury (ALI) is an inflammatory condition for which treatment is mainly supportive due to lack of effective therapies. In this study, the therapeutic effects of ASC-based therapy were assessed in vivo by comparison of the anti-inflammatory properties of both human and murine ASCs in a mouse model of lipopolysaccharide (LPS)-induced ALI. Methods: Human ASCs (hASCs) or mouse ASCs (mASCs) were delivered to C57Bl/6 mice (7.5 × 105 total cells/mouse) by oropharyngeal aspiration (OA) four hours after the animals were challenged with lipopolysaccharide (15 mg/kg). Mice were sacrificed 24 and 72 hours after LPS exposure, and lung histology examined for evaluation of inflammation and injury. Bronchoalveolar lavage fluid (BALF) was analyzed to determine total and differential cell counts, total protein and albumin concentrations, and myeloperoxidase (MPO) activity. Cytokine expression in the injured lungs was measured at the steady-state mRNA levels and protein levels for assessment of the degree of lung inflammation. Results: Both human and mouse ASC treatments provided protective anti-inflammatory responses. There were decreased levels of leukocyte (for example neutrophil) migration into the alveoli, total protein and albumin concentrations in BALF, and MPO activity after the induction of ALI following both therapies. Additionally, cell therapy with both cell types effectively suppressed the expression of proinflammatory cytokines and increased the anti-inflammatory cytokine interleukin 10 (IL-10). Overall, the syngeneic mASC therapy had a more potent therapeutic effect than the xenogeneic hASC therapy in this model. Conclusions: Treatment with hASCs or mASCs significantly attenuated LPS-induced acute lung injury in mice. These results suggest a potential benefit for using an ASC-based therapy to treat clinical ALI and may possibly prevent the development of acute respiratory distress syndrome (ARDS).Keywords
This publication has 40 references indexed in Scilit:
- Obesity‐Associated Dysregulation of Calpastatin and MMP‐15 in Adipose‐Derived Stromal Cells Results in their Enhanced InvasionStem Cells, 2012
- Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-α-induced protein 6Stem Cell Research & Therapy, 2011
- Regenerative Therapy and Cancer: In Vitro and In Vivo Studies of the Interaction Between Adipose-Derived Stem Cells and Breast Cancer Cells from Clinical IsolatesTissue Engineering Part A, 2011
- Mesenchymal Lineage Stem Cells Have Pronounced Anti-Inflammatory Effects in the Twitcher Mouse Model of Krabbe's DiseaseStem Cells, 2010
- Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lungProceedings of the National Academy of Sciences, 2009
- Has Mortality from Acute Respiratory Distress Syndrome Decreased over Time?: A Systematic ReviewAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 productionNature Medicine, 2008
- Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: implications for cell-based therapiesCell and tissue research, 2008
- Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injuryProceedings of the National Academy of Sciences of the United States of America, 2007
- The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitroLife Sciences, 2007